High Tmod3 expression is associated with poor patient prognosis in many types of tumors, including GBM and LGG, cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC), lung adenocarcinoma and adenosquamous carcinama (LUAD and LUSC), PAAD and bladder urothelial carcinoma (BLCA) (Fig. S3C-G). The gene discussed is TMOD3; the disease is pancreatic adenocarcinoma.